Suppliers and packagers for jylamvo

jylamvo

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Shorla	JYLAMVO	methotrexate	SOLUTION;ORAL	212479	NDA	SHORLA ONCOLOGY INC.	81927-204-01	1 BOTTLE, GLASS in 1 CARTON (81927-204-01) / 60 mL in 1 BOTTLE, GLASS	2023-12-15

Suppliers for JYLAMVO (Jylamvo) and Upstream Manufacturing Chain

Last updated: June 2, 2026

JYLAMVO is a US-marketed pharmaceutical product with defined commercial and supply responsibilities across the brand’s marketing authorization holder and its contracted manufacturing network. However, no complete, source-backed supplier roster (API manufacturers, formulation fill-finish sites, labeled packaging vendors, and logistics distributors) can be provided from the information available here.

What companies supply JYLAMVO to US wholesalers and pharmacies?

No supplier list with verifiable names, site addresses, or role mapping (API, drug substance, drug product, fill-finish, packaging, distribution) is available in the provided material for JYLAMVO.

Who is the labeled distributor or marketing authorization holder?

No source-backed information is available here to identify the labeled US distributor, NDA holder, or marketing authorization holder for JYLAMVO.

Which manufacturing contractors produce the API and finished tablets?

No source-backed information is available here to name upstream API suppliers, CDMOs, or fill-finish manufacturers for JYLAMVO.

Which upstream API and excipient suppliers are linked to JYLAMVO?

No source-backed API/starting-material supplier names and excipient vendor identities are available here for JYLAMVO.

Are there multiple API sources or single-supply dependence?

No supply-chain redundancy details (multiple sourcing, alternate routes, or dual manufacturing sites) are available here for JYLAMVO.

What manufacturing sites and fill-finish locations make JYLAMVO?

No facility-level manufacturing or packaging locations for JYLAMVO are available here (no plant names, addresses, or site-role mapping).

How do JYLAMVO supply obligations change during shortages or FDA actions?

No FDA action history, shortage notifications, or supply-impact documentation is available here for JYLAMVO.

What is the competitive supply landscape for JYLAMVO’s active ingredient?

No active ingredient is specified in the provided material, so no competitor supply landscape for that molecule can be constructed from verifiable sources.

Key Takeaways

• A source-backed, complete supplier map for JYLAMVO (API, drug product, fill-finish, packaging, distribution) cannot be produced from the information provided.
• No verifiable supplier names, manufacturing sites, or upstream partners for JYLAMVO are available here.

FAQs

1. Who is the CDMO for JYLAMVO drug product?
   No verified CDMO information is available in the provided material.

2. Which company supplies the active pharmaceutical ingredient for JYLAMVO?
   No verified API supplier information is available in the provided material.

3. Where is JYLAMVO packaged and labeled in the US?
   No verified packaging and labeling sites are available in the provided material.

4. Does JYLAMVO have multiple manufacturing sites to mitigate shortage risk?
   No verified site redundancy or shortage mitigation details are available in the provided material.

5. Which logistics/distribution firms handle JYLAMVO shipments to pharmacies?
   No verified distributor or logistics supplier information is available in the provided material.

References

No sources were provided in the prompt.